A novel synonymous KMT2B variant in a patient with dystonia causes aberrant splicing.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
05 2022
Historique:
revised: 21 02 2022
received: 07 01 2022
accepted: 25 02 2022
pubmed: 17 3 2022
medline: 27 4 2022
entrez: 16 3 2022
Statut: ppublish

Résumé

Heterozygous KMT2B variants are a common cause of dystonia. A novel synonymous KMT2B variant, c.5073C>T (p.Gly1691=) was identified in an individual with childhood-onset progressive dystonia. The splicing impact of c.5073C>T was assessed using an in vitro exon-trapping assay. The genomic region of KMT2B exons 23-26 was cloned into the pSpliceExpress plasmid between exon 2 and 3 of the rat Ins2 gene. The c.5073C>T variant was then introduced through site-directed mutagenesis. The KMT2B wild-type and c.5073C>T plasmids were transfected separately into HeLa cells and RNA was extracted 48 hours after transfection. The RNA was reverse transcribed to produce cDNA, which was PCR amplified using primers annealing to the flanking rat Ins2 sequences. Sanger sequencing of the PCR products revealed that c.5073C>T caused a novel splice donor site and therefore a 5-bp deletion of KMT2B exon 23 in mature mRNA, leading to a coding frameshift and premature stop codon (p.Lys1692AsnfsTer7). To our knowledge, this is the first report of a KMT2B synonymous variant associated with dystonia. Reassessment of synonymous variants may increase diagnostic yield for inherited disorders including monogenic dystonia. This is of clinical importance, given the generally favourable response to deep brain stimulation for KMT2B-related dystonia.

Sections du résumé

BACKGROUND
Heterozygous KMT2B variants are a common cause of dystonia. A novel synonymous KMT2B variant, c.5073C>T (p.Gly1691=) was identified in an individual with childhood-onset progressive dystonia.
METHODS
The splicing impact of c.5073C>T was assessed using an in vitro exon-trapping assay. The genomic region of KMT2B exons 23-26 was cloned into the pSpliceExpress plasmid between exon 2 and 3 of the rat Ins2 gene. The c.5073C>T variant was then introduced through site-directed mutagenesis. The KMT2B wild-type and c.5073C>T plasmids were transfected separately into HeLa cells and RNA was extracted 48 hours after transfection. The RNA was reverse transcribed to produce cDNA, which was PCR amplified using primers annealing to the flanking rat Ins2 sequences.
RESULTS
Sanger sequencing of the PCR products revealed that c.5073C>T caused a novel splice donor site and therefore a 5-bp deletion of KMT2B exon 23 in mature mRNA, leading to a coding frameshift and premature stop codon (p.Lys1692AsnfsTer7).
CONCLUSION
To our knowledge, this is the first report of a KMT2B synonymous variant associated with dystonia. Reassessment of synonymous variants may increase diagnostic yield for inherited disorders including monogenic dystonia. This is of clinical importance, given the generally favourable response to deep brain stimulation for KMT2B-related dystonia.

Identifiants

pubmed: 35293157
doi: 10.1002/mgg3.1923
pmc: PMC9034664
doi:

Substances chimiques

RNA Splice Sites 0
Histone-Lysine N-Methyltransferase EC 2.1.1.43
KMT2B protein, human EC 2.1.1.43

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1923

Informations de copyright

© 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Références

Nat Genet. 2017 Feb;49(2):223-237
pubmed: 27992417
Am J Hum Genet. 2016 Dec 1;99(6):1377-1387
pubmed: 27839873
Parkinsonism Relat Disord. 2019 Dec;69:111-118
pubmed: 31731261
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Am J Hum Genet. 2018 Jan 4;102(1):175-187
pubmed: 29276005
Clin Genet. 2021 Dec;100(6):743-747
pubmed: 34477219
Front Genet. 2019 Oct 07;10:914
pubmed: 31649718
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Parkinsonism Relat Disord. 2019 Jun;63:227-228
pubmed: 30196991
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
Front Neurol. 2021 Jan 08;11:630391
pubmed: 33488508
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
Gene. 2008 Dec 31;427(1-2):104-10
pubmed: 18930792
Mol Genet Genomic Med. 2022 May;10(5):e1923
pubmed: 35293157
JAMA Psychiatry. 2017 Mar 1;74(3):293-299
pubmed: 28097321
Brain. 2020 Dec 5;143(11):3242-3261
pubmed: 33150406
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868

Auteurs

Bianca R Grosz (BR)

Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, New South Wales, Australia.

Stephen Tisch (S)

Department of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Michel C Tchan (MC)

Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Department of Genetic Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Victor S C Fung (VSC)

Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Movement Disorders Unit, Neurology Department, Westmead Hospital, Westmead, New South Wales, Australia.

Paul Darveniza (P)

Department of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.

Avi Fellner (A)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Department of Neurology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Manju A Kurian (MA)

Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, London, UK.

Alison McLean (A)

Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.

Susan E Tomlinson (SE)

Department of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Renee Smyth (R)

Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.

Sophie Devery (S)

Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.

Kathy H C Wu (KHC)

School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
School of Medicine, University of Notre Dame, Fremantle, Australia.

Marina L Kennerson (ML)

Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, New South Wales, Australia.
Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, New South Wales, Australia.

Kishore R Kumar (KR)

Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Molecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Department of Neurology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH